FDA Approves New PARP Inhibitor for Ovarian Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
Tag: FDA
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
A look at the 10 most-read posts of the year on Cancer Research Catalyst illustrates the steady pace of...
Before you try to banish the winter blues by adding some color to your skin with a trip to...
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...